HUTCHMED (China) (HCM) Income from Non-Controlling Interests (2015 - 2021)

HUTCHMED (China)'s (HCM) quarterly Income from Non-Controlling Interests came in at -$27.6 million in Q4 2021, down 1464.4% on a QoQ basis from -$1.8 million in Q2 2021.

HUTCHMED (China) (HCM) Income from Non-Controlling Interests (2015 - 2021) Analysis & Trends

HUTCHMED (China) (HCM) has 6 years of Income from Non-Controlling Interests data on file, last reported at -$27.6 million in Q4 2021.

  • On a quarterly basis, Income from Non-Controlling Interests changed N/A year-over-year to -$27.6 million in Q4 2021; TTM through Dec 2021 was -$31.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$105818.5, down 87.23% from the prior year.
  • Income from Non-Controlling Interests for Q4 2021 stood at -$27.6 million, down from -$1.8 million in the prior quarter.
  • Over the last five years, Income from Non-Controlling Interests for HCM reached as high as $3.9 million in Q2 2018 and fell as low as -$27.6 million in Q4 2021.
  • Historically, Income from Non-Controlling Interests has averaged -$2.4 million across 4 years, with a median of -$715000.0 in 2020.
  • Across the five-year window, Income from Non-Controlling Interests jumped 158.79% in 2019 and plunged 191.78% in 2020, its largest moves.
  • Year by year, Income from Non-Controlling Interests stood at $788000.0 in 2018, then tumbled by 172.84% to -$574000.0 in 2019, then fell by 27.7% to -$733000.0 in 2020, then slumped by 3671.21% to -$27.6 million in 2021.
  • Per Business Quant data, the three most recent Income from Non-Controlling Interests figures were -$27.6 million in Q4 2021, -$1.8 million in Q2 2021, and -$1.3 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn -
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 395,346.10
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn -
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn -12.70 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn -
10 HUTCHMED (China) 9.45 Bn 9.45 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2021 -27.64 Mn
Jun 30, 2021 -1.77 Mn
Mar 31, 2021 -1.29 Mn
Jun 30, 2020 -733,000.00
Mar 31, 2020 -715,000.00
Dec 31, 2019 -574,000.00
Sep 30, 2019 143,000.00
Jun 30, 2019 -2.69 Mn
Mar 31, 2019 779,000.00
Dec 31, 2018 788,000.00
Sep 30, 2018 165,000.00
Jun 30, 2018 3.89 Mn
Mar 31, 2018 -1.33 Mn
Jun 30, 2016 -37,000.00
Jun 30, 2015 67,000.00